Home Cart 0 Sign in  

[ CAS No. 90213-67-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 90213-67-5
Chemical Structure| 90213-67-5
Structure of 90213-67-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 90213-67-5 ]

Related Doc. of [ 90213-67-5 ]

Alternatived Products of [ 90213-67-5 ]

Product Details of [ 90213-67-5 ]

CAS No. :90213-67-5 MDL No. :MFCD13189421
Formula : C7H5Cl2N3 Boiling Point : -
Linear Structure Formula :- InChI Key :WIROGLUDZOMAPT-UHFFFAOYSA-N
M.W : 202.04 Pubchem ID :25230953
Synonyms :

Calculated chemistry of [ 90213-67-5 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.14
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.81
TPSA : 30.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.38
Log Po/w (XLOGP3) : 2.54
Log Po/w (WLOGP) : 2.28
Log Po/w (MLOGP) : 1.7
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 2.22

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.25
Solubility : 0.114 mg/ml ; 0.000565 mol/l
Class : Soluble
Log S (Ali) : -2.83
Solubility : 0.298 mg/ml ; 0.00147 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.34
Solubility : 0.0928 mg/ml ; 0.000459 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.58

Safety of [ 90213-67-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 90213-67-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 90213-67-5 ]
  • Downstream synthetic route of [ 90213-67-5 ]

[ 90213-67-5 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 90213-66-4 ]
  • [ 74-88-4 ]
  • [ 90213-67-5 ]
YieldReaction ConditionsOperation in experiment
98%
Stage #1: With sodium hydride In tetrahydrofuran; acetonitrile at 0℃; for 0.5 h;
Stage #2: at 0 - 20℃;
To a solution of sodium hydride (480 mg, 12.00 mmol, 1.10 equiv, 60percent) in tetrahydrofuran (50 mL), a solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (2 g, 10.64 mmol, 1.00 equiv) in tetrahydrofuran (50 mL) was slowly added.
The resulting solution was stirred at 0° C. for 30 min followed by the addition of methyl iodide (1.66 g, 11.70 mmol, 1.10 equiv) at 0° C.
The mixture was stirred at room temperature overnight.
After completion, 20 mL of water was added to the mixture and the solution was extracted with ethyl acetate and washed with brine.
The organic phase was dried over anhydrous sodium sulfate, filtered and then concentrated under vacuum.
The residue was purified by silica gel column chromatography eluting with ethyl acetate/petroleum ether (1:5) to afford 2.1 g (98percent) of 2,4-dichloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine as a white solid. LC-MS (ES, m/z): 202 [M+H]
97.2%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.333333 h;
Stage #2: at 20℃; for 3 h;
[00237] To a solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.5 g, 7.98 mmol) in THF (30 ml) at 0 °C was added sodium hydride (60percent oil suspension, 383 mg, 9.57 mmol) and stirred at 0 °C to r.t. for 20 mins. lodomethane (0.6 ml, 9.57 mmol) was added and stirred at r.t. for 3 h. [00238] The mixture was quenched by addition of saturated ammonium chloride solution (20 mL). EtOAc was then added resulting in formation of a precipitate. The precipitate was filtered and the filtrate extracted with EtOAc (x2). The combined organic fractions were washed with water, dried over Na2S04, filtered and concentrated in vacuo to afford the title compound (1.65 g, 97.2percent) as a yellow powder. [00239] Method A: LC-MS m/z = 201.90, 203.90 [M + H]+; RT = 1.21 min.
96%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 0.5 h;
Stage #2: at 20℃; for 3 h;
Step 1 : To a stirred solution of 2,4-dichloro-7/-/-pyrrolo[2,3-c]pyrimidine (2 g, 10.638 mmol) in DMF (20 mL) was added 60 percent NaH (0.63 g, 15.957 mmol, 1.5 equiv) at 0 °C and stirred for 30 min at room temperature. Methyl iodide (0.79 mL, 12.765 mol, 1.2 equiv) was added and allowed to stir at room temperature for 3 h. The reaction was quenched with ice water (200 mL) and the precipitated solid was filtered and dried in vacuo to obtain 2,4-dichloro-7-methyl- 7H-pyrrolo[2,3-c]pyrimidine as an off white solid (2.06 g, 96 percent). LCMS (ES) m/z = 202.1 , 204.0 [M+H]+. H NMR (400 MHz, DMSO-d6) δ ppm 3.80 (s, 3H), 6.66 (d, J = 3.2 Hz, 1 H), 7.73 (d, J = 3.2 Hz, 1 H).
93% With triethylamine In tetrahydrofuran at 25℃; for 6 h; A solution of2,4-Dichloro-7H-pyrrolo [2,3-d] pyrimidine (5.0 g, 26.6 mmol) was dissolved in tetrahydrofuran (50 mL)Triethylamine (4.0 g, 39.5 mmol) was added,Methyl iodide (4.2 g, 29.6 mmol) was added dropwise,After the addition was complete, the temperature was raised to 25 ° C and reacted for 16 hours.After the reaction was completed, the reaction solution was poured into water (100 mL)The precipitated solid was filtered,drying,The product (5.0 g, 93percent yield) was obtained.
93%
Stage #1: With sodium hydroxide In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 20℃;
A 0 °C solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.00 g, 5.32 mmol) in THF (8 mL) was stirred for 5 mm, then to the solution was added sodium hydroxide (255 mg, 6.38 mmol). The mixture was stirred for further 15 mm, and iodomethane (8.50 g, 53.20 mmol) was added. The mixture was stirred at rt overnight. To the reaction mixture was added H20 (100 mL), and the mixture was extracted with EtOAc (50 mL x 3). The combined organic layers were washed with saturated brine (80 mL), dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated in vacuo dry,and the residue was purified by silica gel column chromatography (PE/EtOAc (v/v) = 10/1) to give the title compound as a white solid (1.00 g, 93 percent).MS (ESI, pos. ion) m/z: 202.95 [M+Hfb.
93%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 20℃;
2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.00 g, 5.32 mmol)Dissolved in THF (8 mL), and the resulting solution was stirred at 0 ° C for 5 min.Then sodium hydride (255 mg, 6.38 mmol) was added thereto.The resulting reaction solution was stirred for 15 minutes.Methyl iodide (8.50 g, 53.20 mmol) was added thereto.The resulting reaction solution was transferred to room temperature and stirred overnight.The reaction was quenched by H2O (EtOAc) (EtOAc)The combined organic phases were washed with brine (80 mL).Dry over anhydrous sodium sulfate, filter, and concentrate the filtrate under reduced pressure.The residue was chromatographed on silica gel ( petroleum ether / ethyl acetate (v/v) = 10/1)Purification to give the title compound as a white solid(1.00g, 93percent).
93%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 20℃;
A solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (1.00 g, 5.32 mmol) in THF (8 mL) was stirred at 0 °C for 5 mm. Then sodium hydride (255 mg, 6.38 mmol) was added. The resulting mixture was stirred for 15 mm, then iodomethane (8.50 g, 53.20 mmol) was added. The reaction mixture was warmed to rt and stirred overnight. H20 (100 mL) was added to quench the reaction, and the resulting mixture was extracted with EtOAc (50 mL x 3). The combined organic phases were washed with brine (80 mL), dried over anhydrous Na2504, filtered, and the filtrate was concentrated in vacuo. The residue was purified by silica gel chromatograph (PE/EtOAc (v/v) = 10/1) to give the tilte compound as a white solid (1.00 g, 93 percent).MS (ESI, pos. ion) m/z: 203.0 [M+H]t
93%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 0 - 20℃;
A solution of 2, 4-dichloro-7H-pyrrolo [2, 3-d] pyrimidine (1.00 g, 5.32 mmol) in THF (8 mL) was stirred for 5 min at 0 , then sodium hydride (255 mg, 6.38 mmol) was added. The mixture was stirred for 15 min, and then iodomethane (8.50 g, 53.20 mmol) was added. The resulting mixture was warm to rt and stirred overnight, then the reaction was quenched with H2O (100 mL) . The mixture was extracted with ethyl acetate (50 mL × 3) . The combined organic layers were washed with saturated brine (80 mL) , dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated in vacuo, and the residue was purified by silica gel column chromatography (PE/EtOAc (v/v) =10/1) to give the title compound as a white solid (1.00 g, 93percent) .MS (ESI, pos. ion) m/z: 203.0 [M+H]+.
84.1%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.5 h;
Stage #2: at 0 - 20℃;
To a solution of 60percent NaH (750 mg) in dry THF (20 mL), a solution of 18a (1.7 g) in dry THF (50 mL) was slowly added. The resulting solution was stirred at 0 °C for 30 min followed by the addition of MeI (0.79 mL) at 0 °C. The mixture was stirred at room temperature overnight. After the addition of 20 mL water, the solution was extracted with ether (3.x.10 mL) and washed with saturated brine. The organic phase was dried with anhydrous sodium sulfate and filtered. Ether was evaporated in vacuo to yield a crude residue, which was purified by silica gel chromatography (PE/EA= 10/1) to give 18d (1.53 g, yield: 84.1percent). ESI-MS calculated for (C7H5Cl2N3) [M+H]+, 202.0, found 202.1.
74.1%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃;
Stage #2: at 20℃;
A solution of 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine (3.00 g, 16.0 mmol) in anhydrous tetrahydrofuran (45 mL) was cooled to 0° C. and treated with a 60percent dispersion of sodium hydride in mineral oil (0.83 g, 20.8 mmol). The reaction was stirred at 0° C. for 20-30 min. The reaction was then treated with iodomethane (3.65 g, 1.6 mL, 25.7 mmol), and the reaction stirred at room temperature overnight. The reaction was diluted with a saturated aqueous ammonium chloride solution (50 mL) and water (50 mL) and was extracted with a 10percent methanol in methylene chloride solution (4×50 mL). The combined organic layers were dried over magnesium sulfate, filtered and rinsed with methylene chloride, and concentrated in vacuo onto Celite®. Flash chromatography (80 g silica gel column, 0-15percent ethyl acetate/hexanes) afforded 2,4-dichloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine as a light yellow solid (2.39 g, 74.1percent). 1H NMR (400 MHz, DMSO-d6) δ ppm 3.81 (s, 3H) 6.70 (d, J=3.51 Hz, 1H) 7.76 (d, J=3.51 Hz, 1H). LC-MS calcd. for C7H6Cl2N3 [(M+H)+] 202, obsd. 202.0.
58%
Stage #1: With sodium hydride In acetonitrile at 0 - 20℃; for 0.333333 h;
Stage #2: at 20℃; for 1 h;
To a solution of 2,4-dichloro-7H-pyrrolo[2,3-djpyrimidine 34 (237 mg, 1.26 mmol) in CH3CN (1 mL) was added NaH (33.3 mg, 1.39 mmol) portion- wise at 0 °C. The reaction mixture was stirred at room temperature for 20 mm until gas evolution was ceased. Methyl iodide (86.4 i.il, 1.39 mmol) was added and stirred the reaction mixture for 1 h at room temperature. To the reaction mixture was added water and extracted with ethyl acetate (2 x 30 mL). The combined organic layers were dried over Mg504, and then concentrated under vacuum. The resultant crude residue was purified by silica-gel column chromatography to afford 35 (144 mg, 58percent) as white solid. ‘H-NMR (400 MHz, DMSO-d6) ö 7.76 (d, J = 3.6 Hz, 1H), 6.71 (d, J = 3.6 Hz, 1H), 3.81 (s, 3H); MS: (m/z) [M+Hjb 204.02.

Reference: [1] Patent: US2015/57260, 2015, A1, . Location in patent: Paragraph 0436; 0437; 0588; 0589
[2] Patent: WO2015/25026, 2015, A1, . Location in patent: Page/Page column 118
[3] Patent: WO2017/59191, 2017, A1, . Location in patent: Paragraph 00235-00239
[4] Patent: WO2017/46739, 2017, A1, . Location in patent: Page/Page column 51
[5] Patent: CN107226808, 2017, A, . Location in patent: Paragraph 0366-0369
[6] Patent: WO2018/33082, 2018, A1, . Location in patent: Paragraph 00262
[7] Patent: CN108276401, 2018, A, . Location in patent: Paragraph 0554; 0556; 0557; 0920; 0922; 0923
[8] Patent: WO2018/127096, 2018, A1, . Location in patent: Paragraph 00273; 00370
[9] Patent: WO2018/157830, 2018, A1, . Location in patent: Paragraph 00243
[10] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 205 - 212
[11] Journal of Medicinal Chemistry, 2014, vol. 57, # 1, p. 144 - 158
[12] Patent: US2013/331375, 2013, A1, . Location in patent: Paragraph 0153-0154
[13] Liebigs Annalen der Chemie, 1984, # 4, p. 722 - 733
[14] Patent: WO2018/137036, 2018, A1, . Location in patent: Paragraph 00235; 00236
[15] Patent: WO2010/38060, 2010, A1, . Location in patent: Page/Page column 90-91
  • 2
  • [ 90213-66-4 ]
  • [ 90213-67-5 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With sodium hydride In tetrahydrofuran at 0℃; for 0.25 h;
Stage #2: at 20℃;
A 0 oc solution of 2,4-dichloro-7 H-pyrrolo[2,3-d]pyrimidine ( 1.00 g, 5.32 mmol) inTHF (8 mL) was stirred at 0 oc for 5 min. Then sodium hydride (255 mg, 6.38 mmol) was added.The resulting mixture was stirred for 15 min, then iodomethane (8.50 g, 53.20 mmol) was added.The reaction mixture was warmed to rt and stirred overnight. To the reaction mixture was addedwater (60 mL) to quench the reaction, and the resulting mixture was extracted with ethyl acetate(50 mL x 3). The combined organic layers were washed with saturated brine (80 mL), dried overanhydrous sodium sulfate and filtered. The filtrate was concentrated and the residue was purified by silica gel column chromatography (PE/EtOAc (v/v) = 1011) to give the title compound as awhite solid (1.00 g, 93 percent ).MS (ESI, pos. ion) m/z: 202.0[M+Ht.
83% With potassium hydroxide In dimethyl sulfoxide at 20℃; for 1 h; Example 2 (1 g, 5.318 mmol) and powdered KOH (446 mg, 7.978 mmol) was dissolved in 4 mL anhydrous DMSO. After 1 h at RT, the reaction mixture was quenched with water and the aqueous layer was extracted with EtOAc (2x).The organics were combined, dried (MgSO4), filtered and the volatiles were removed in vacuo. The residue was purified by flash chromatography (Siψ2, hexanes/EtOAc, 2:1 ) to provide the desired product (892 mg, 83percent) as a colourless solid. 1H NMR (CZ6-DMSO) δ 7.76 (1 H, d, J = 3.6 Hz), 6.70 (1 H, d, J= 3.6 Hz), 3.82 (3H, s).
Reference: [1] Patent: WO2018/108125, 2018, A1, . Location in patent: Paragraph 00339
[2] Patent: WO2009/37467, 2009, A1, . Location in patent: Page/Page column 16-17; 13
  • 3
  • [ 84955-31-7 ]
  • [ 90213-67-5 ]
Reference: [1] Liebigs Annalen der Chemie, 1984, # 4, p. 722 - 733
  • 4
  • [ 52133-67-2 ]
  • [ 90213-67-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 205 - 212
  • 5
  • [ 39929-79-8 ]
  • [ 90213-67-5 ]
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 52, p. 205 - 212
  • 6
  • [ 39929-79-8 ]
  • [ 90213-67-5 ]
Reference: [1] Patent: WO2018/137036, 2018, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 90213-67-5 ]

Chlorides

Chemical Structure| 90213-66-4

[ 90213-66-4 ]

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.96

Chemical Structure| 7781-10-4

[ 7781-10-4 ]

4-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.91

Chemical Structure| 1192711-71-9

[ 1192711-71-9 ]

2,4-Dichloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.90

Chemical Structure| 1060816-67-2

[ 1060816-67-2 ]

2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 3680-69-1

[ 3680-69-1 ]

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Related Parent Nucleus of
[ 90213-67-5 ]

Other Aromatic Heterocycles

Chemical Structure| 90213-66-4

[ 90213-66-4 ]

2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.96

Chemical Structure| 7781-10-4

[ 7781-10-4 ]

4-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.91

Chemical Structure| 1192711-71-9

[ 1192711-71-9 ]

2,4-Dichloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.90

Chemical Structure| 1060816-67-2

[ 1060816-67-2 ]

2-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87

Chemical Structure| 3680-69-1

[ 3680-69-1 ]

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.87